LARC Acceptance, Subdermal Implant Uptake, And Follow-Up Response in Women Seeking Contraceptive Advice

Objectives: To determine the acceptance of Long-Acting Reversible Contraceptives (LARC) and uptake of subdermal implants and follow-up response in women seeking contraceptive advice. Study Design: Observational case series. Place and Duration of the Study: Gynecology OPD and family planning center B...

Full description

Bibliographic Details
Main Author: Rakhshanda Neelofar, Shama Jogezai, Fozia Muhammad Bakhsh, Safia Bibi, Pari Gul
Format: Article
Language:English
Published: Riphah International University, Islamabad 2022-03-01
Series:Journal of Islamic International Medical College
Online Access:https://journals.riphah.edu.pk/index.php/jiimc/article/view/634
Description
Summary:Objectives: To determine the acceptance of Long-Acting Reversible Contraceptives (LARC) and uptake of subdermal implants and follow-up response in women seeking contraceptive advice. Study Design: Observational case series. Place and Duration of the Study: Gynecology OPD and family planning center Bolan Medical Complex Hospital Quetta, January 02, 2018, to December 30, 2019. Materials and Methods: Women found eligible for Long-Acting Reversible Contraceptives, amongst those seeking contraceptive advice, were included in this study after informed consent. The women found eligible were given the choice of Long-acting contraceptives. Women, who opted for Intrauterine Contraceptive Device were referred to the familyplanning center and those who accepted subdermal implants were sent to gynae minor operation theater after informed consent. Microsoft Excel was used for the analysis of data. Mean and standard deviation was calculated for quantitative data. Frequencies and percentages were calculated for qualitative data. Results: A total number of 3670 women seeking contraception were advised long-acting reversible contraceptives. Whereas 1423(38.77%) accepted long-acting reversible contraceptives amongst the women who opted for it, 64.23% accepted subdermal implants and 35.76% opted for intrauterine contraceptive devices. Out of 1423 women who accepted long-acting reversible contraceptives, only 25 % turned out for follow-up. Discontinuation of long-acting reversible contraceptives was observed in both subdermal groups (8.09%) and intrauterine contraceptive device groups (4.51%) during 1st year of initiation. Conclusion: Acceptance of long-acting reversible contraceptives (LARC) and uptake of subdermal implants is reasonable among the women seeking contraceptive advice. These contraceptive methods may be offered as first-line contraceptives for most women provided that the cost barrier is eliminated.
ISSN:1815-4018
2410-5422